Medifast
MED
153 hedge funds and large institutions have $344M invested in Medifast in 2016 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 9 closing their positions.
3,634% more call options, than puts
Call options by funds: $1.2M | Put options by funds: $32K
233% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 9
36% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 42
15% more funds holding
Funds holding: 133 → 153 (+20)
11% more capital invested
Capital invested by funds: $311M → $344M (+$32.9M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.61% less ownership
Funds ownership: 87.91% → 87.29% (-0.61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$4.06M |
| 2 |
Two Sigma Investments
New York
|
+$3.45M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$3.04M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.92M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$40.8M |
| 2 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$2.51M |
| 3 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$1.03M |
| 4 |
Bank of New York Mellon
New York
|
-$663K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$642K |
MED Hedge Fund Activity: Q2 2016 in Review
153 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2016, worth a combined $344M — up 11% from $311M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new MED positions and 9 closed out — a net gain of 21 holders — while 57 added to existing stakes and 42 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $4.06M. The largest seller was Visium Asset Management, exiting entirely with an estimated $40.8M sold.
- 153 institutional investors held Medifast (MED) as of Q2 2016, up from 133 in Q1 2016.
- Funds reported $344M of Medifast stock for Q2 2016, up 11% quarter-over-quarter.
- 30 funds opened new Medifast positions in Q2 2016 and 9 closed out, a net change of +21 holders.
- The largest Medifast buyer in Q2 2016 was Renaissance Technologies, an estimated $4.06M added.
- The largest Medifast seller in Q2 2016 was Visium Asset Management, an estimated $40.8M sold.
Based on aggregated 13F filings for Q2 2016.